SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-20-000082
Filing Date
2020-05-05
Accepted
2020-05-05 16:07:11
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20200331.htm   iXBRL 10-Q 1315942
2 EX-31.1 lfvn033120ex311.htm EX-31.1 11332
3 EX-31.2 lfvn033120ex312.htm EX-31.2 11321
4 EX-32.1 lfvn033120ex321.htm EX-32.1 6028
5 EX-32.2 lfvn033120ex322.htm EX-32.2 6017
  Complete submission text file 0000849146-20-000082.txt   4750795

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20200331.xsd EX-101.SCH 24783
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20200331_cal.xml EX-101.CAL 64060
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20200331_def.xml EX-101.DEF 106304
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20200331_lab.xml EX-101.LAB 402115
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20200331_pre.xml EX-101.PRE 237983
45 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20200331_htm.xml XML 700936
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 20848850
SIC: 2834 Pharmaceutical Preparations